nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—embryo—ovarian cancer	0.0385	0.211	CbGeAlD
Pentosan Polysulfate—FGF4—female reproductive system—ovarian cancer	0.0233	0.128	CbGeAlD
Pentosan Polysulfate—FGF2—myometrium—ovarian cancer	0.0142	0.078	CbGeAlD
Pentosan Polysulfate—FGF2—uterine cervix—ovarian cancer	0.0111	0.0607	CbGeAlD
Pentosan Polysulfate—FGF2—decidua—ovarian cancer	0.0105	0.0578	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—ovarian cancer	0.0102	0.0558	CbGeAlD
Pentosan Polysulfate—FGF2—endometrium—ovarian cancer	0.01	0.0549	CbGeAlD
Pentosan Polysulfate—FGF2—uterus—ovarian cancer	0.00922	0.0506	CbGeAlD
Pentosan Polysulfate—FGF1—epithelium—ovarian cancer	0.0083	0.0455	CbGeAlD
Pentosan Polysulfate—FGF2—female gonad—ovarian cancer	0.00754	0.0414	CbGeAlD
Pentosan Polysulfate—FGF2—vagina—ovarian cancer	0.0075	0.0411	CbGeAlD
Pentosan Polysulfate—FGF2—testis—ovarian cancer	0.00669	0.0367	CbGeAlD
Pentosan Polysulfate—FGF1—female reproductive system—ovarian cancer	0.00617	0.0338	CbGeAlD
Pentosan Polysulfate—FGF1—female gonad—ovarian cancer	0.00561	0.0308	CbGeAlD
Pentosan Polysulfate—FGF1—testis—ovarian cancer	0.00498	0.0273	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—ovarian cancer	0.00485	0.0266	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—ovarian cancer	0.00361	0.0198	CbGeAlD
Pentosan Polysulfate—Decreased appetite—Topotecan—ovarian cancer	0.000791	0.00282	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Melphalan—ovarian cancer	0.000784	0.00279	CcSEcCtD
Pentosan Polysulfate—Haematuria—Paclitaxel—ovarian cancer	0.000782	0.00279	CcSEcCtD
Pentosan Polysulfate—Constipation—Topotecan—ovarian cancer	0.000778	0.00277	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—ovarian cancer	0.000776	0.00276	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Melphalan—ovarian cancer	0.000774	0.00276	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Paclitaxel—ovarian cancer	0.000774	0.00276	CcSEcCtD
Pentosan Polysulfate—Infection—Vinorelbine—ovarian cancer	0.000773	0.00275	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Paclitaxel—ovarian cancer	0.00077	0.00274	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—ovarian cancer	0.000766	0.00273	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000762	0.00271	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Docetaxel—ovarian cancer	0.00076	0.00271	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—ovarian cancer	0.000758	0.0027	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—ovarian cancer	0.000758	0.0027	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Chlorambucil—ovarian cancer	0.000753	0.00268	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Topotecan—ovarian cancer	0.00075	0.00267	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—ovarian cancer	0.000745	0.00265	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Topotecan—ovarian cancer	0.000744	0.00265	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vinorelbine—ovarian cancer	0.000742	0.00264	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Paclitaxel—ovarian cancer	0.000739	0.00263	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—ovarian cancer	0.000733	0.00261	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Paclitaxel—ovarian cancer	0.000731	0.0026	CcSEcCtD
Pentosan Polysulfate—Pruritus—Chlorambucil—ovarian cancer	0.000723	0.00258	CcSEcCtD
Pentosan Polysulfate—Urticaria—Topotecan—ovarian cancer	0.000723	0.00257	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Topotecan—ovarian cancer	0.000719	0.00256	CcSEcCtD
Pentosan Polysulfate—Weight increased—Docetaxel—ovarian cancer	0.00071	0.00253	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—ovarian cancer	0.000709	0.00253	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000709	0.00253	CcSEcCtD
Pentosan Polysulfate—Urticaria—Melphalan—ovarian cancer	0.000708	0.00252	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Docetaxel—ovarian cancer	0.000706	0.00251	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—ovarian cancer	0.000702	0.0025	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—ovarian cancer	0.000702	0.0025	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Chlorambucil—ovarian cancer	0.000699	0.00249	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vinorelbine—ovarian cancer	0.000699	0.00249	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Vinorelbine—ovarian cancer	0.000694	0.00247	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—ovarian cancer	0.000693	0.00247	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Paclitaxel—ovarian cancer	0.000687	0.00245	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Docetaxel—ovarian cancer	0.000678	0.00242	CcSEcCtD
Pentosan Polysulfate—Jaundice—Docetaxel—ovarian cancer	0.000678	0.00242	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vinorelbine—ovarian cancer	0.000676	0.00241	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Docetaxel—ovarian cancer	0.000676	0.00241	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Topotecan—ovarian cancer	0.00067	0.00239	CcSEcCtD
Pentosan Polysulfate—Constipation—Vinorelbine—ovarian cancer	0.000665	0.00237	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Melphalan—ovarian cancer	0.000656	0.00234	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Docetaxel—ovarian cancer	0.000656	0.00234	CcSEcCtD
Pentosan Polysulfate—Alopecia—Paclitaxel—ovarian cancer	0.000651	0.00232	CcSEcCtD
Pentosan Polysulfate—Vomiting—Chlorambucil—ovarian cancer	0.00065	0.00231	CcSEcCtD
Pentosan Polysulfate—Pruritus—Topotecan—ovarian cancer	0.000644	0.00229	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—ovarian cancer	0.000642	0.00229	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Vinorelbine—ovarian cancer	0.000641	0.00228	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000636	0.00227	CcSEcCtD
Pentosan Polysulfate—Flatulence—Paclitaxel—ovarian cancer	0.000632	0.00225	CcSEcCtD
Pentosan Polysulfate—Pruritus—Melphalan—ovarian cancer	0.00063	0.00224	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Docetaxel—ovarian cancer	0.000626	0.00223	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Topotecan—ovarian cancer	0.000622	0.00222	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Docetaxel—ovarian cancer	0.00062	0.00221	CcSEcCtD
Pentosan Polysulfate—Urticaria—Vinorelbine—ovarian cancer	0.000618	0.0022	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vinorelbine—ovarian cancer	0.000615	0.00219	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Melphalan—ovarian cancer	0.000609	0.00217	CcSEcCtD
Pentosan Polysulfate—Nausea—Chlorambucil—ovarian cancer	0.000607	0.00216	CcSEcCtD
Pentosan Polysulfate—Dizziness—Topotecan—ovarian cancer	0.000601	0.00214	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—ovarian cancer	0.000599	0.00213	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000595	0.00212	CcSEcCtD
Pentosan Polysulfate—Anaemia—Paclitaxel—ovarian cancer	0.000593	0.00211	CcSEcCtD
Pentosan Polysulfate—Agitation—Paclitaxel—ovarian cancer	0.000589	0.0021	CcSEcCtD
Pentosan Polysulfate—Vomiting—Topotecan—ovarian cancer	0.000578	0.00206	CcSEcCtD
Pentosan Polysulfate—Malaise—Paclitaxel—ovarian cancer	0.000578	0.00206	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—ovarian cancer	0.000577	0.00205	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Paclitaxel—ovarian cancer	0.000574	0.00204	CcSEcCtD
Pentosan Polysulfate—Rash—Topotecan—ovarian cancer	0.000574	0.00204	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vinorelbine—ovarian cancer	0.000573	0.00204	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Topotecan—ovarian cancer	0.000573	0.00204	CcSEcCtD
Pentosan Polysulfate—Headache—Topotecan—ovarian cancer	0.00057	0.00203	CcSEcCtD
Pentosan Polysulfate—Vomiting—Melphalan—ovarian cancer	0.000566	0.00202	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—ovarian cancer	0.000566	0.00202	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—ovarian cancer	0.000562	0.002	CcSEcCtD
Pentosan Polysulfate—Rash—Melphalan—ovarian cancer	0.000562	0.002	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Melphalan—ovarian cancer	0.000561	0.002	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—ovarian cancer	0.000554	0.00198	CcSEcCtD
Pentosan Polysulfate—Alopecia—Docetaxel—ovarian cancer	0.000552	0.00197	CcSEcCtD
Pentosan Polysulfate—Pruritus—Vinorelbine—ovarian cancer	0.000551	0.00196	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Paclitaxel—ovarian cancer	0.000546	0.00194	CcSEcCtD
Pentosan Polysulfate—Myalgia—Paclitaxel—ovarian cancer	0.000546	0.00194	CcSEcCtD
Pentosan Polysulfate—Nausea—Topotecan—ovarian cancer	0.00054	0.00192	CcSEcCtD
Pentosan Polysulfate—Discomfort—Paclitaxel—ovarian cancer	0.000539	0.00192	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—ovarian cancer	0.000539	0.00192	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—ovarian cancer	0.000534	0.0019	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vinorelbine—ovarian cancer	0.000532	0.0019	CcSEcCtD
Pentosan Polysulfate—Nausea—Melphalan—ovarian cancer	0.000529	0.00188	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—ovarian cancer	0.000524	0.00187	CcSEcCtD
Pentosan Polysulfate—Oedema—Paclitaxel—ovarian cancer	0.000523	0.00186	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00052	0.00185	CcSEcCtD
Pentosan Polysulfate—Infection—Paclitaxel—ovarian cancer	0.00052	0.00185	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vinorelbine—ovarian cancer	0.000515	0.00183	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—ovarian cancer	0.000513	0.00183	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000512	0.00183	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000506	0.0018	CcSEcCtD
Pentosan Polysulfate—Anaemia—Docetaxel—ovarian cancer	0.000502	0.00179	CcSEcCtD
Pentosan Polysulfate—Anorexia—Paclitaxel—ovarian cancer	0.000499	0.00178	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—ovarian cancer	0.000499	0.00178	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vinorelbine—ovarian cancer	0.000495	0.00176	CcSEcCtD
Pentosan Polysulfate—Rash—Vinorelbine—ovarian cancer	0.000491	0.00175	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vinorelbine—ovarian cancer	0.00049	0.00175	CcSEcCtD
Pentosan Polysulfate—Headache—Vinorelbine—ovarian cancer	0.000487	0.00174	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Docetaxel—ovarian cancer	0.000487	0.00173	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—ovarian cancer	0.000486	0.00173	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00048	0.00171	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—ovarian cancer	0.000479	0.00171	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000477	0.0017	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—ovarian cancer	0.000476	0.0017	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—ovarian cancer	0.000474	0.00169	CcSEcCtD
Pentosan Polysulfate—Insomnia—Paclitaxel—ovarian cancer	0.000473	0.00169	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Paclitaxel—ovarian cancer	0.00047	0.00167	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Paclitaxel—ovarian cancer	0.000467	0.00166	CcSEcCtD
Pentosan Polysulfate—Myalgia—Docetaxel—ovarian cancer	0.000463	0.00165	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Docetaxel—ovarian cancer	0.000463	0.00165	CcSEcCtD
Pentosan Polysulfate—Nausea—Vinorelbine—ovarian cancer	0.000462	0.00165	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Paclitaxel—ovarian cancer	0.000461	0.00164	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—ovarian cancer	0.000457	0.00163	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—ovarian cancer	0.000457	0.00163	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—ovarian cancer	0.000456	0.00162	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Paclitaxel—ovarian cancer	0.000455	0.00162	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—ovarian cancer	0.00045	0.0016	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—ovarian cancer	0.00045	0.0016	CcSEcCtD
Pentosan Polysulfate—Constipation—Paclitaxel—ovarian cancer	0.000448	0.00159	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—ovarian cancer	0.000447	0.00159	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000444	0.00158	CcSEcCtD
Pentosan Polysulfate—Oedema—Docetaxel—ovarian cancer	0.000444	0.00158	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—ovarian cancer	0.000443	0.00158	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—ovarian cancer	0.000442	0.00158	CcSEcCtD
Pentosan Polysulfate—Infection—Docetaxel—ovarian cancer	0.000441	0.00157	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—ovarian cancer	0.00044	0.00157	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—ovarian cancer	0.00044	0.00157	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Docetaxel—ovarian cancer	0.000434	0.00155	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Paclitaxel—ovarian cancer	0.000431	0.00154	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000428	0.00152	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—ovarian cancer	0.000423	0.00151	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—ovarian cancer	0.000423	0.00151	CcSEcCtD
Pentosan Polysulfate—Anorexia—Docetaxel—ovarian cancer	0.000423	0.00151	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—ovarian cancer	0.000422	0.0015	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—ovarian cancer	0.000422	0.0015	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—ovarian cancer	0.000418	0.00149	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—ovarian cancer	0.000416	0.00148	CcSEcCtD
Pentosan Polysulfate—Urticaria—Paclitaxel—ovarian cancer	0.000416	0.00148	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—ovarian cancer	0.000414	0.00147	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Paclitaxel—ovarian cancer	0.000414	0.00147	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—ovarian cancer	0.000409	0.00146	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—ovarian cancer	0.000407	0.00145	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000404	0.00144	CcSEcCtD
Pentosan Polysulfate—Insomnia—Docetaxel—ovarian cancer	0.000401	0.00143	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Docetaxel—ovarian cancer	0.000398	0.00142	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Docetaxel—ovarian cancer	0.000395	0.00141	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—ovarian cancer	0.000393	0.0014	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—ovarian cancer	0.000391	0.00139	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Docetaxel—ovarian cancer	0.00039	0.00139	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—ovarian cancer	0.000387	0.00138	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Docetaxel—ovarian cancer	0.000386	0.00137	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Paclitaxel—ovarian cancer	0.000386	0.00137	CcSEcCtD
Pentosan Polysulfate—Constipation—Docetaxel—ovarian cancer	0.000379	0.00135	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—ovarian cancer	0.000372	0.00133	CcSEcCtD
Pentosan Polysulfate—Pruritus—Paclitaxel—ovarian cancer	0.00037	0.00132	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Docetaxel—ovarian cancer	0.000366	0.0013	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—ovarian cancer	0.000363	0.00129	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000363	0.00129	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—ovarian cancer	0.000361	0.00129	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Paclitaxel—ovarian cancer	0.000358	0.00128	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Docetaxel—ovarian cancer	0.000351	0.00125	CcSEcCtD
Pentosan Polysulfate—Dizziness—Paclitaxel—ovarian cancer	0.000346	0.00123	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—ovarian cancer	0.000344	0.00123	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—ovarian cancer	0.00034	0.00121	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—ovarian cancer	0.000339	0.00121	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—ovarian cancer	0.000337	0.0012	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—ovarian cancer	0.000334	0.00119	CcSEcCtD
Pentosan Polysulfate—Vomiting—Paclitaxel—ovarian cancer	0.000333	0.00119	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—ovarian cancer	0.000331	0.00118	CcSEcCtD
Pentosan Polysulfate—Rash—Paclitaxel—ovarian cancer	0.00033	0.00118	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Paclitaxel—ovarian cancer	0.00033	0.00117	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—ovarian cancer	0.000328	0.00117	CcSEcCtD
Pentosan Polysulfate—Headache—Paclitaxel—ovarian cancer	0.000328	0.00117	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Docetaxel—ovarian cancer	0.000327	0.00116	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000315	0.00112	CcSEcCtD
Pentosan Polysulfate—Pruritus—Docetaxel—ovarian cancer	0.000314	0.00112	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—ovarian cancer	0.000314	0.00112	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—ovarian cancer	0.000312	0.00111	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—ovarian cancer	0.000312	0.00111	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—ovarian cancer	0.000312	0.00111	CcSEcCtD
Pentosan Polysulfate—Nausea—Paclitaxel—ovarian cancer	0.000311	0.00111	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—ovarian cancer	0.000308	0.0011	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—ovarian cancer	0.000306	0.00109	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—ovarian cancer	0.000304	0.00108	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Docetaxel—ovarian cancer	0.000304	0.00108	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—ovarian cancer	0.000299	0.00107	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—ovarian cancer	0.000297	0.00106	CcSEcCtD
Pentosan Polysulfate—Dizziness—Docetaxel—ovarian cancer	0.000293	0.00104	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—ovarian cancer	0.000293	0.00104	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—ovarian cancer	0.000289	0.00103	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—ovarian cancer	0.000289	0.00103	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—ovarian cancer	0.000289	0.00103	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—ovarian cancer	0.000285	0.00102	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—ovarian cancer	0.000285	0.00102	CcSEcCtD
Pentosan Polysulfate—Vomiting—Docetaxel—ovarian cancer	0.000282	0.001	CcSEcCtD
Pentosan Polysulfate—Rash—Docetaxel—ovarian cancer	0.00028	0.000996	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Docetaxel—ovarian cancer	0.000279	0.000995	CcSEcCtD
Pentosan Polysulfate—Headache—Docetaxel—ovarian cancer	0.000278	0.00099	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—ovarian cancer	0.000277	0.000986	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—ovarian cancer	0.000275	0.00098	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000273	0.000971	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000271	0.000966	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—ovarian cancer	0.000271	0.000964	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—ovarian cancer	0.000269	0.000957	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000268	0.000953	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—ovarian cancer	0.000267	0.00095	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—ovarian cancer	0.000264	0.00094	CcSEcCtD
Pentosan Polysulfate—Nausea—Docetaxel—ovarian cancer	0.000263	0.000939	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—ovarian cancer	0.000263	0.000938	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—ovarian cancer	0.00026	0.000927	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—ovarian cancer	0.000256	0.000911	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000252	0.000899	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—ovarian cancer	0.00025	0.000892	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—ovarian cancer	0.000249	0.000886	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—ovarian cancer	0.000247	0.000879	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—ovarian cancer	0.000247	0.000878	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000245	0.000872	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—ovarian cancer	0.000244	0.000868	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—ovarian cancer	0.000241	0.000857	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—ovarian cancer	0.000238	0.000847	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—ovarian cancer	0.000237	0.000843	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—ovarian cancer	0.000237	0.000843	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000228	0.000813	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000226	0.000806	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—ovarian cancer	0.00022	0.000785	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—ovarian cancer	0.00022	0.000783	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—ovarian cancer	0.000219	0.00078	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—ovarian cancer	0.000212	0.000754	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—ovarian cancer	0.000205	0.000729	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—ovarian cancer	0.000204	0.000727	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—ovarian cancer	0.000198	0.000705	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—ovarian cancer	0.000196	0.000698	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—ovarian cancer	0.00019	0.000678	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—ovarian cancer	0.000189	0.000675	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—ovarian cancer	0.000189	0.000672	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—ovarian cancer	0.000188	0.000671	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—ovarian cancer	0.000187	0.000668	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—ovarian cancer	0.000183	0.000652	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—ovarian cancer	0.000178	0.000633	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—ovarian cancer	0.000176	0.000627	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—ovarian cancer	0.000175	0.000622	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—ovarian cancer	0.000174	0.000621	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—ovarian cancer	0.000173	0.000618	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—ovarian cancer	0.000164	0.000586	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CDKN1B—ovarian cancer	6.56e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ESR1—ovarian cancer	6.54e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—ovarian cancer	6.5e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—ovarian cancer	6.45e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—ovarian cancer	6.43e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6ST—ovarian cancer	6.43e-05	0.00012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—STAT3—ovarian cancer	6.37e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—ovarian cancer	6.36e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—ovarian cancer	6.36e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CDKN1B—ovarian cancer	6.35e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PTEN—ovarian cancer	6.33e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6ST—ovarian cancer	6.32e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PTEN—ovarian cancer	6.29e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—ovarian cancer	6.26e-05	0.000117	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APC—ovarian cancer	6.18e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CG—ovarian cancer	6.18e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—ovarian cancer	6.15e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CAV1—ovarian cancer	6.15e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK3—ovarian cancer	6.09e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TERT—ovarian cancer	6.06e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PTEN—ovarian cancer	6.04e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—ovarian cancer	6.01e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR4—ovarian cancer	6.01e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—ovarian cancer	6e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—ovarian cancer	5.91e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK3—ovarian cancer	5.89e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PPP2R1A—ovarian cancer	5.86e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTEN—ovarian cancer	5.84e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6ST—ovarian cancer	5.83e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK1—ovarian cancer	5.79e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—ovarian cancer	5.79e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6ST—ovarian cancer	5.76e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STAT3—ovarian cancer	5.66e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—ovarian cancer	5.65e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—ovarian cancer	5.61e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CAV1—ovarian cancer	5.61e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK1—ovarian cancer	5.61e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—ovarian cancer	5.61e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APC—ovarian cancer	5.6e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDH1—ovarian cancer	5.58e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—ovarian cancer	5.47e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CD—ovarian cancer	5.43e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK3—ovarian cancer	5.41e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—ovarian cancer	5.39e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—ovarian cancer	5.38e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK3—ovarian cancer	5.38e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PPP2R1A—ovarian cancer	5.35e-05	9.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CD—ovarian cancer	5.33e-05	9.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6ST—ovarian cancer	5.32e-05	9.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—ovarian cancer	5.3e-05	9.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STAT3—ovarian cancer	5.23e-05	9.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—ovarian cancer	5.21e-05	9.71e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK1—ovarian cancer	5.15e-05	9.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—ovarian cancer	5.15e-05	9.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK1—ovarian cancer	5.11e-05	9.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—ovarian cancer	5.11e-05	9.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APC—ovarian cancer	5.11e-05	9.52e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDH1—ovarian cancer	5.09e-05	9.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—ovarian cancer	5.09e-05	9.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK3—ovarian cancer	4.99e-05	9.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CD—ovarian cancer	4.93e-05	9.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—ovarian cancer	4.91e-05	9.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—PIK3CA—ovarian cancer	4.87e-05	9.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CD—ovarian cancer	4.86e-05	9.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—ovarian cancer	4.86e-05	9.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—ovarian cancer	4.86e-05	9.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—ovarian cancer	4.83e-05	9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ERBB2—ovarian cancer	4.8e-05	8.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK1—ovarian cancer	4.75e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—ovarian cancer	4.75e-05	8.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MTOR—ovarian cancer	4.74e-05	8.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CB—ovarian cancer	4.74e-05	8.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ERBB2—ovarian cancer	4.71e-05	8.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—PIK3CA—ovarian cancer	4.67e-05	8.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TERT—ovarian cancer	4.66e-05	8.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CB—ovarian cancer	4.65e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MTOR—ovarian cancer	4.65e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—ovarian cancer	4.65e-05	8.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—ovarian cancer	4.64e-05	8.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—ovarian cancer	4.55e-05	8.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—ovarian cancer	4.5e-05	8.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CD—ovarian cancer	4.49e-05	8.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—ovarian cancer	4.49e-05	8.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—PIK3CA—ovarian cancer	4.47e-05	8.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—ovarian cancer	4.45e-05	8.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CDKN1B—ovarian cancer	4.45e-05	8.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—PIK3CA—ovarian cancer	4.44e-05	8.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CDKN1B—ovarian cancer	4.36e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CASP3—ovarian cancer	4.36e-05	8.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—ERBB2—ovarian cancer	4.35e-05	8.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—ovarian cancer	4.35e-05	8.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—ovarian cancer	4.32e-05	8.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—ovarian cancer	4.31e-05	8.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CAV1—ovarian cancer	4.31e-05	8.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ERBB2—ovarian cancer	4.3e-05	8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTOR—ovarian cancer	4.29e-05	8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CB—ovarian cancer	4.29e-05	8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—ovarian cancer	4.27e-05	7.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—PIK3CA—ovarian cancer	4.26e-05	7.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TERT—ovarian cancer	4.25e-05	7.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—ovarian cancer	4.24e-05	7.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MTOR—ovarian cancer	4.24e-05	7.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CB—ovarian cancer	4.24e-05	7.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—ovarian cancer	4.2e-05	7.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—ovarian cancer	4.15e-05	7.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—ovarian cancer	4.13e-05	7.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PIK3CA—ovarian cancer	4.12e-05	7.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—ovarian cancer	4.12e-05	7.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—ovarian cancer	4.12e-05	7.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—ovarian cancer	4.11e-05	7.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—ovarian cancer	4.11e-05	7.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PTEN—ovarian cancer	4.09e-05	7.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6ST—ovarian cancer	4.08e-05	7.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CDKN1B—ovarian cancer	4.03e-05	7.5e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTEN—ovarian cancer	4.02e-05	7.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CDKN1B—ovarian cancer	3.98e-05	7.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—ovarian cancer	3.98e-05	7.4e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ERBB2—ovarian cancer	3.97e-05	7.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—ovarian cancer	3.95e-05	7.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—ovarian cancer	3.94e-05	7.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—ovarian cancer	3.93e-05	7.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CAV1—ovarian cancer	3.93e-05	7.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—ovarian cancer	3.92e-05	7.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APC—ovarian cancer	3.92e-05	7.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTOR—ovarian cancer	3.92e-05	7.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CB—ovarian cancer	3.92e-05	7.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—ovarian cancer	3.89e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—ovarian cancer	3.82e-05	7.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—ovarian cancer	3.81e-05	7.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—ovarian cancer	3.81e-05	7.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—ovarian cancer	3.79e-05	7.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—ovarian cancer	3.76e-05	7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6ST—ovarian cancer	3.72e-05	6.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTEN—ovarian cancer	3.71e-05	6.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—ovarian cancer	3.7e-05	6.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CDKN1B—ovarian cancer	3.67e-05	6.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTEN—ovarian cancer	3.66e-05	6.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—ovarian cancer	3.66e-05	6.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—ovarian cancer	3.65e-05	6.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—ovarian cancer	3.65e-05	6.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—ovarian cancer	3.65e-05	6.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—ovarian cancer	3.63e-05	6.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—ovarian cancer	3.59e-05	6.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—ovarian cancer	3.58e-05	6.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—ovarian cancer	3.58e-05	6.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APC—ovarian cancer	3.58e-05	6.66e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—ovarian cancer	3.5e-05	6.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—ovarian cancer	3.48e-05	6.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—ovarian cancer	3.47e-05	6.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CD—ovarian cancer	3.45e-05	6.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—ovarian cancer	3.43e-05	6.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—ovarian cancer	3.4e-05	6.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTEN—ovarian cancer	3.38e-05	6.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—ovarian cancer	3.37e-05	6.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK1—ovarian cancer	3.33e-05	6.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—ovarian cancer	3.33e-05	6.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—ovarian cancer	3.32e-05	6.18e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—ovarian cancer	3.31e-05	6.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—ovarian cancer	3.28e-05	6.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—ovarian cancer	3.27e-05	6.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK1—ovarian cancer	3.27e-05	6.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—ovarian cancer	3.27e-05	6.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—ovarian cancer	3.17e-05	5.9e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CD—ovarian cancer	3.15e-05	5.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—ovarian cancer	3.14e-05	5.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—ovarian cancer	3.13e-05	5.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—ovarian cancer	3.09e-05	5.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—ovarian cancer	3.08e-05	5.74e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ERBB2—ovarian cancer	3.05e-05	5.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—ovarian cancer	3.03e-05	5.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—ovarian cancer	3.02e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK1—ovarian cancer	3.02e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—ovarian cancer	3.02e-05	5.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CB—ovarian cancer	3.01e-05	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MTOR—ovarian cancer	3.01e-05	5.6e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK1—ovarian cancer	2.98e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—ovarian cancer	2.98e-05	5.55e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—ovarian cancer	2.89e-05	5.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—ovarian cancer	2.89e-05	5.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CA—ovarian cancer	2.89e-05	5.38e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—ovarian cancer	2.85e-05	5.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PIK3CA—ovarian cancer	2.83e-05	5.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CDKN1B—ovarian cancer	2.82e-05	5.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—ovarian cancer	2.81e-05	5.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—ovarian cancer	2.81e-05	5.24e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—ovarian cancer	2.79e-05	5.2e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ERBB2—ovarian cancer	2.78e-05	5.17e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CASP3—ovarian cancer	2.77e-05	5.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—ovarian cancer	2.76e-05	5.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK1—ovarian cancer	2.75e-05	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—ovarian cancer	2.75e-05	5.12e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MTOR—ovarian cancer	2.74e-05	5.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CB—ovarian cancer	2.74e-05	5.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—ovarian cancer	2.69e-05	5.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—ovarian cancer	2.67e-05	4.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—ovarian cancer	2.67e-05	4.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—ovarian cancer	2.63e-05	4.91e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—ovarian cancer	2.62e-05	4.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PIK3CA—ovarian cancer	2.62e-05	4.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—ovarian cancer	2.61e-05	4.87e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PTEN—ovarian cancer	2.6e-05	4.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—ovarian cancer	2.6e-05	4.84e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PIK3CA—ovarian cancer	2.59e-05	4.81e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CDKN1B—ovarian cancer	2.57e-05	4.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—ovarian cancer	2.56e-05	4.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CASP3—ovarian cancer	2.52e-05	4.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—ovarian cancer	2.52e-05	4.69e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—ovarian cancer	2.51e-05	4.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—ovarian cancer	2.45e-05	4.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—ovarian cancer	2.43e-05	4.53e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—ovarian cancer	2.42e-05	4.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—ovarian cancer	2.39e-05	4.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PIK3CA—ovarian cancer	2.39e-05	4.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—ovarian cancer	2.38e-05	4.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PTEN—ovarian cancer	2.37e-05	4.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—ovarian cancer	2.36e-05	4.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—ovarian cancer	2.35e-05	4.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—ovarian cancer	2.32e-05	4.33e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—ovarian cancer	2.32e-05	4.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—ovarian cancer	2.32e-05	4.32e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—ovarian cancer	2.32e-05	4.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—ovarian cancer	2.29e-05	4.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—ovarian cancer	2.22e-05	4.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—ovarian cancer	2.21e-05	4.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—ovarian cancer	2.16e-05	4.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—ovarian cancer	2.14e-05	3.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—ovarian cancer	2.14e-05	3.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—ovarian cancer	2.12e-05	3.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—ovarian cancer	2.11e-05	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—ovarian cancer	2.11e-05	3.94e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK1—ovarian cancer	2.11e-05	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—ovarian cancer	2.11e-05	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—ovarian cancer	2.11e-05	3.93e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—ovarian cancer	2.02e-05	3.77e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—ovarian cancer	1.99e-05	3.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—ovarian cancer	1.97e-05	3.67e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—ovarian cancer	1.95e-05	3.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK1—ovarian cancer	1.93e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—ovarian cancer	1.93e-05	3.59e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CA—ovarian cancer	1.83e-05	3.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—ovarian cancer	1.82e-05	3.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—ovarian cancer	1.77e-05	3.3e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—ovarian cancer	1.7e-05	3.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CA—ovarian cancer	1.67e-05	3.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—ovarian cancer	1.62e-05	3.02e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—ovarian cancer	1.62e-05	3.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—ovarian cancer	1.55e-05	2.88e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—ovarian cancer	1.5e-05	2.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—ovarian cancer	1.48e-05	2.76e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—ovarian cancer	1.37e-05	2.54e-05	CbGpPWpGaD
